Regulus Therapeutics
RGLS
#6949
Rank
ยฃ0.42 B
Marketcap
ยฃ6.13
Share price
0.00%
Change (1 day)
414.18%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of March 2025 : ยฃ49.06 Million

According to Regulus Therapeutics's latest financial reports the company has ยฃ49.06 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ60.38 M223.68%
2023-12-31ยฃ18.65 M-42.37%
2022-12-31ยฃ32.36 M-27.64%
2021-12-31ยฃ44.73 M96.14%
2020-12-31ยฃ22.8 M-12.35%
2019-12-31ยฃ26.02 M137.03%
2018-12-31ยฃ10.97 M-75.3%
2017-12-31ยฃ44.44 M-27.94%
2016-12-31ยฃ61.68 M-19.86%
2015-12-31ยฃ76.96 M-24.98%
2014-12-31ยฃ0.10 B48.45%
2013-12-31ยฃ69.11 M13.87%
2012-12-31ยฃ60.69 M147.32%
2011-12-31ยฃ24.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
GlaxoSmithKline
GSK
ยฃ3.33 B 6,699.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
ยฃ7.84 B 15,889.32%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ2.97 B 5,958.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ6.14 B 12,416.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
ยฃ2.04 B 4,068.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ22.23 M-54.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.38 B 25,144.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA